VAXCYTE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 71.63 USD | +6.39% |
|
+7.25% | +14.06% |
Chart calendar Vaxcyte, Inc.
3a7724ec09b3f6be543cb5965.eGSX16wK3R734zdJkVrK-dCqEItltyMraa-ValUzXsI.VTTmrpQ4u3KPjwIYyx6nz6XeZeULzUwZEfbfKwEGOoQPHvqu70a_VcKGYg~889ff8a204c0d2a2e94b56562ebe7aa1
Upcoming events on Vaxcyte, Inc.
Past events on Vaxcyte, Inc.
| 2024-05-14 12:20 pm | BofA Securities Health Care Conference |
| 2024-05-08 04:05 pm | Q1 2024 Earnings Release |
| 2024-04-09 12:45 pm | Needham Healthcare Conference |
| 2024-03-12 | Jefferies Biotech on the Bay Summit |
| 2024-03-12 08:40 am | Leerink Partners Global Biopharma Conference |
| 2024-03-05 02:10 pm | TD Cowen Health Care Conference |
| 2024-02-27 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-27 04:01 pm | Q4 2023 Earnings Release |
| 2024-02-08 10:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 2023-11-28 08:20 am | Evercore ISI HealthCONx Conference |
| 2023-11-14 03:00 am | Jefferies London Healthcare Conference |
| 2023-11-07 11:10 am | Guggenheim Securities Inflammation & Immunology Conference |
| 2023-11-06 04:03 pm | Q3 2023 Earnings Release |
| 2023-09-26 11:40 am | Cantor Global Healthcare Conference |
| 2023-08-08 04:03 pm | Q2 2023 Earnings Release |
| 2023-06-13 11:30 am | Annual General Meeting |
| 2023-06-08 10:30 am | Jefferies Global Healthcare Conference |
| 2023-05-10 05:20 pm | Bank of America Healthcare Conference |
| 2023-05-07 | Q1 2023 Earnings Release |
| 2023-04-17 07:30 am | VAX-24 Phase 2 Study Results Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -88,2 -89,8 1.79% | -102 -98,0 -3.93% | -230 -211 -8.85% | -465 -324 -43.51% | -480 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -89,6 -95,8 6.46% | -104 -103 -0.85% | -232 -216 -7.32% | -468 -386 -21.32% | -501 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -89,2 -95,5 6.58% | -100 -101 1.04% | -223 -216 -3.44% | -402 -331 -21.65% | -454 |
|
Net income Million USD | Released Forecast Spread | -50,3 | -89,2 -93,4 4.53% | -100 -100 0.04% | -223 -214 -4.19% | -402 -328 -22.55% | -452 |
|
EPS USD | Released Forecast Spread | -13,2 | -3,02 -2,81 -7.47% | -1,93 -1,89 -2.25% | -3,44 -3,33 -3.17% | -4,14 -3,49 -18.75% | -4,01 |
| Announcement Date | 22/05/20 | 29/03/21 | 28/02/22 | 27/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -196 -54,6 -258.36% | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -39,2 -35,8 -9.56% | -47,9 -40,6 -18.04% | -58,6 -50,5 -16.07% | -86,6 -70,7 -22.38% | -71,2 -67,8 -5.03% | -87,1 -74,3 -17.34% | -113 -89,6 -26.1% | -197 -114 -71.88% | -114 -124 7.67% | -121 | -128 | -136 | -127 | -129 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -39,0 -35,5 -9.92% | -48,5 -40,5 -19.73% | -57,9 -50,4 -14.84% | -78,1 -70,6 -10.59% | -60,5 -68,6 11.8% | -68,3 -70,5 3% | -92,7 -83,8 -10.62% | -181 -119 -51.64% | -95,0 -125 24.26% | -108 | -116 | -130 | -127 | -129 |
|
Net income Million USD | Released Forecast Spread | -39,0 -35,5 -9.92% | -48,5 -40,5 -19.73% | -57,9 -50,4 -14.84% | -78,1 -69,0 -13.11% | -60,5 -65,3 7.44% | -68,3 -69,3 1.34% | -92,7 -81,0 -14.47% | -181 -106 -70.23% | -95,0 -120 20.77% | -111 | -116 | -128 | -127 | -129 |
|
EPS USD | Released Forecast Spread | -0,68 -0,63 -8.51% | -0,80 -0,69 -15.94% | -0,93 -0,84 -11.15% | -1,02 -0,93 -9.68% | -0,70 -0,82 14.89% | -0,70 -0,75 6.04% | -0,91 -0,84 -8.66% | -1,82 -1,07 -69.7% | -0,85 -1,13 25.03% | -0,98 | -1,02 | -1,12 | -1,10 | -1,15 |
| Announcement Date | 09/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 08/08/23 | 06/11/23 | 27/02/24 | 08/05/24 | - | - | - | - | - |
| 2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-07-23 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-25 01:00 am | ARGENX SE: Q2 2024 Earnings Release |
| 2024-07-29 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-30 | CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Vaxcyte, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PCVX Stock
- Calendar Vaxcyte, Inc.
